title: Photodynamic therapy and central serous chorioretinopathy.
abstract: Central serous chorioretinopathy is a common acquired maculopathy. Multiple studies showed that photodynamic therapy is useful treatment for acute and chronic central serous chorioretinopathy. The exact mechanism of photodynamic therapy in treating central serous chorioretinopathy is not clear, but it is thought to be caused by short-term choriocapillaris hypoperfusion and long-term choroidal vascular remodeling, leading to a reduction in choroidal congestion, vascular hyperpermeability and extravascular leakage. Furthermore, photodynamic therapy seems to be an effective means of improving or stabilizing visual acuity in patients with central serous chorioretinopathy.
authors.affiliation: Eye Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania.
authors.forename: Lina
authors.initials: L
authors.lastname: Siaudvytyte
authors.affiliation: Eye Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania.
authors.forename: Vaida
authors.initials: V
authors.lastname: Diliene
authors.affiliation: Eye Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania.
authors.forename: Goda
authors.initials: G
authors.lastname: Miniauskiene
authors.affiliation: Eye Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania.
authors.forename: Vilma Jurate
authors.initials: VJ
authors.lastname: Balciuniene
keywords: Central serous chorioretinopathy; Pathophysiology; Photodynamic therapy